Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 14.5.2025Accord Healthcare S.L.U (ACC-ES)3852EDabigatran etexilate Accord 110 mg tvrdé kapsuly (cps dur 60x1x110 mg (blis.OPA/Al/DES PE-PET/Al/PE - jednotl.d.))14.5.2025O
 14.5.2025Accord Healthcare S.L.U (ACC-ES)3862EDabigatran etexilate Accord 150 mg tvrdé kapsuly (cps dur 60x1x150 mg (blis.OPA/Al/DES PE-PET/Al/PE - jednotl.d.))14.5.2025O
 14.5.2025Accord Healthcare S.L.U (ACC-ES)8430AMemantine Accord 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/PE/PVDC/Al))14.5.2025O
 14.5.2025Viatris Limited (VIM)7529ENilotinib Viatris 200 mg (cps dur 112x200 mg (blis.PVC/PE/PVDC//Al))14.5.2025R
 14.5.2025Accord Healthcare Polska Sp. z o.o. (AOK)2773ATopotecan Accord 1 mg/ml koncentrát na infúzny roztok (con inf 1x1 ml/1 mg (liek.inj.skl.jantárová))14.5.2025O
 14.5.2025Viatris Limited (VIM)7521ENilotinib Viatris 150 mg (cps dur 112x150 mg (blis.PVC/PE/PVDC//Al))14.5.2025R
 7.5.2025Viatris Healthcare Limited (VIM-1)87130Allergodil (aer nao 1x10 ml (fľ.skl.hnedá))14.5.2025R
 14.5.2025Accord Healthcare S.L.U (ACC-ES)1149EZOLSKETIL pegylated liposomal 2 mg/ml koncentrát na infúznu disperziu (con dsf 1x10 ml/20 mg (liek.inj.skl.))14.5.2025R
 14.5.2025Accord Healthcare Polska Sp. z o.o. (AOK)2494AGemcitabine Accord 100 mg/ml infúzny koncentrát (con inf 1x200 mg/2 ml (liek.inj.skl.))14.5.2025R
 14.5.2025Accord Healthcare Polska Sp. z o.o. (AOK)07859Quetiapine Accord 100 mg filmom obalené tablety (tbl flm 60x100 mg (blis.PVC/Al))14.5.2025O
 14.5.2025Allergy Therapeutics Ibérica, S.L.U. (AGT-5)28410POLLINEX Tree (sus inj 3x0,5 ml (striek.inj.1-300 SU+striek.inj.2-800 SU+striek.inj.3-2000 SU))13.5.2025R
 14.5.2025Allergy Therapeutics Ibérica, S.L.U. (AGT-5)28202POLLINEX Rye (sus inj 3x0,5 ml (striek.inj.3-2 000 SU))13.5.2025R
 14.5.2025Allergy Therapeutics Ibérica, S.L.U. (AGT-5)28203POLLINEX Tree (sus inj 3x0,5 ml (striek.inj.3-2000 SU))13.5.2025R
 13.5.2025B.Braun Melsungen AG (BME)21434Remifentanil B. Braun 1 mg (plc ifu 5x1 mg (liek.inj.skl.))13.5.2025R
 13.5.2025G.L. Pharma GmbH (GLH-2)2700EJansitin Duo 50 mg/1 000 mg filmom obalené tablety (tbl flm 196x50 mg/1 000 mg (blis.PVC/PVDC/Al))13.5.2025R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)